PS Ratio: 11.63

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

Is the P/S ratio high or low?

The P/S ratio of 11.63 is 24% below its estimated 2-year average of 15.35, near the low end of its estimated 2-year range (3.30–118.46).

As of 2026-10-06T19:13:19.756Z. 46.86% below its estimated 12-month average of 21.89.

PYXS PS Ratio Metrics

P/S vs. estimated history

At 11.63, P/S is near its estimated 2-year median — higher than 42% of readings in its estimated 2-year history.

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

Sales Valuation

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Pyxis Oncology, Inc. (PYXS)?

The P/S ratio for PYXS stock is 11.63.

Is Pyxis Oncology, Inc.'s P/S ratio high or low?

The P/S ratio of 11.63 is 24% below its estimated 2-year average of 15.35, near the low end of its estimated 2-year range (3.30–118.46).

What is the estimated TTM average P/S ratio for Pyxis Oncology, Inc. (PYXS)?

The estimated TTM average P/S ratio for PYXS stock is 21.89.

Showing the most recent 260 of 537 data points. The chart above shows the full history.

Related Metrics